Metronidazole-induced encephalopathy caused by... (2019 study) Skip to main content
Clinical Study Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2019

Metronidazole-induced encephalopathy caused by hyperbaric oxygen therapy in a patient with mandibular osteomyelitis.

Yamamoto Y, Asai N, Furuhashi A, Ono T, Yamagishi Y, Mikamo H, et al., Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The authors described one man with a jaw bone infection who developed nerve and balance symptoms while on an antibiotic and also receiving hyperbaric oxygen therapy.

What They Found

This case report describes a 68-year-old man with mandibular osteomyelitis who developed metronidazole-induced encephalopathy after 47 days of metronidazole, with brain MRI showing hyperintense lesions in the cerebellar dentate nuclei. He received metronidazole for 49 days and hyperbaric oxygen therapy five times. His symptoms included peripheral neuropathy, speech disturbance, nausea and disturbance of gait. His ataxic symptoms improved in 15 days after metronidazole was stopped. The authors say this is the first report of this kind of encephalopathy that could be related to hyperbaric oxygen therapy, as far as they had searched.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

This is a single case report, so it cannot show that hyperbaric oxygen therapy contributed to the encephalopathy or how often this happens, and the abstract states the onset rate of the condition is unclear.

This plain-language summary was generated with AI assistance from the study's abstract; it has not been individually reviewed by a clinician. Always consult the source study and a qualified healthcare professional. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Infection
Source Pubmed
PubMed ID 31204183
Year Published 2019
Journal Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
MeSH Terms Aged; Anti-Bacterial Agents; Cerebellar Ataxia; Cerebellar Nuclei; Chemoradiotherapy; Drug Therapy, Combination; Humans; Hyperbaric Oxygenation; Magnetic Resonance Imaging; Mandibular Diseases; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Neoadjuvant Therapy; Osteomyelitis; Radiation Injuries

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last updated: April 1, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology